news tirzepatide FDA says the weight-loss drug shortage is over FDA says compounding pharmacies can

The FDA officially announced semaglutide on shortage in March 2022, followed by tirzepatide and dulaglutide in December 2022, and liraglutide in July 2023.(8) Even today, two years later, the supply of these medications remains sparse

That loss of muscle mass means potentially losing gains in performance and metabolic rate

If you become pregnant while on tirzepatide, contact your doctor

Midi Health and the Medical Groups are not enrolled with and are not participating providers with state healthcare programs (i.e., Medi-Cal, Medicaid)

Though the risk of side effects are low with microdoses, some patients may experience mild side effects like nausea, vomiting, upset stomach, diarrhea, or similar gastrointestinal side effects after the initial doses

If you need pain relief, discuss safer alternatives with your doctor